Abstract
Most antiviral or immunomodulatory therapies investigated for use in patients with COVID-19 have failed to show any mortality benefit. Similar to the previous pandemics caused by respiratory viruses, the role and benefit of corticosteroids has been under debate in COVID-19-related pulmonary disease. In this consult, we discuss the evidence regarding the efficacy of corticosteroid use in hospitalized patients with COVID-19, including data from the first randomized controlled trial on this subject.
Cite
CITATION STYLE
Chatterjee, K., Wu, C.-P., Bhardwaj, A., & Siuba, M. (2020). Steroids in COVID-19: An overview. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.87a.ccc059
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
